October 11, 2018
Ionis CEO Stanley Crooke at the Carlsbad company’s office. Ionis drug Tegsedi recently won U.S. Food and Drug Administration approval. File Photo by Jamie Scott Lytle
Stories this photo appears in:
Ionis Pharmaceuticals’ drug for a rare genetic disorder recently gained regulatory approval, a relief to investors worried about a denial, and pitting the company against Alnylam Pharmaceuticals.